Pieter Van Der Veken Selected Research

Adenocarcinoma

1/2021	ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma.
9/2016	Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pieter Van Der Veken Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 09/2016
3	Necrosis 11/2018 - 03/2016
2	Adenocarcinoma 01/2021 - 09/2016
2	Inflammation (Inflammations) 10/2020 - 08/2019
2	Hypersensitivity (Allergy) 01/2018 - 12/2017
2	Atherosclerosis 01/2018 - 02/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 10/2020
1	Hemolysis 08/2019
1	Infections 05/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2019
1	Temporal Lobe Epilepsy 03/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 03/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Visceral Pain 01/2018
1	Colitis 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Asthma (Bronchial Asthma) 12/2017
1	Atopic Dermatitis (Atopic Eczema) 12/2017
1	Amyloid Plaque 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Rupture 01/2010
1	Atherosclerotic Plaque (Atheroma) 01/2010

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	UAMC-2526IBA 01/2021 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2017
2	Serine Proteases (Serine Protease)IBA 10/2020 - 01/2018
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2020 - 01/2018
2	Prolyl OligopeptidasesIBA 08/2019 - 03/2019
2	IronIBA 11/2018 - 03/2016
1	Gemcitabine FDA Link 01/2021
1	trypsin-like serine proteaseIBA 10/2020
1	TrypsinIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 08/2019
1	Biomarkers (Surrogate Marker)IBA 08/2019
1	hemoglobin ASIBA 08/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	Kainic Acid (Kainate)IBA 03/2019
1	AntioxidantsIBA 11/2018
1	LipidsIBA 11/2018
1	ferrostatin-1IBA 11/2018
1	tozasertibIBA 01/2018
1	Tryptases (Tryptase)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	AcidsIBA 01/2018
1	Saline SolutionIBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	CytokinesIBA 12/2017
1	Thymic Stromal LymphopoietinIBA 12/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2017
1	Peptides (Polypeptides)IBA 09/2016
1	fibroblast activation protein alphaIBA 09/2016
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2016
1	AminopeptidasesIBA 09/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2016
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 03/2016
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 02/2016
1	dipalmitoylphosphatidylserineIBA 02/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	CholesterolIBA 01/2010
1	Contrast MediaIBA 01/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 01/2017
2	Therapeutics 01/2021 - 01/2018
1	Embolic Protection Devices 01/2010